Coaching & Support
Tools & Resources
Who We Are
What We Do
Not sure where to start?
Home > Funding Programs > mCannabis.RealWorld
The mCannabis.RealWorld (Real-World Evaluation of Cannabis Medicines) Program provides up to $300,000 to support research projects that are addressing urgent clinical or policy knowledge gaps related to the efficacy and safety of cannabis.
On This Page
The mCannabis.RealWorld Program is the first of its kind, addressing urgent clinical or policy knowledge gaps related to the efficacy and safety of cannabis in a real-world setting. The information gathered from these projects can provide evidence about the health outcomes of diverse patient populations and provide important economic insights to inform clinical or policy decisions.
Applicants can receive up to $300,000 to support approved projects over a maximum term of 24 months. Successful Expression of Interest applicants will be eligible to receive up to an additional $10,000 to support proposal development.
A unique feature of the mCannabis.RealWorld Program is an opportunity to access a panel of leading industry members, academics, clinicians, research facilitators and other health care agents. This panel will support applicants by helping them strengthen their proposals and identify collaborative opportunities.
Applicants who participate in mCannabis.RealWorld can expect the following outcomes:
AICE Concepts Program Guide
Full program and application details can be found in the program guide.
More information on the Application process can be found in the program guide.
All applications are reviewed and evaluated to determine fit with the mCannabis.RealWorld Program
objectives and intended outcomes. Alberta Innovates’ staff and external expert reviewers are engaged to evaluate applications.
Full details available in the Program Guide.
Director, Research - Health Innovation
The mCannabis.RealWorld Program provides up to $300,000 to support research projects that are addressing urgent clinical or policy knowledge gaps related to the efficacy and safety of cannabis.
Registration closed: June 1, 2023
Program is currently closed for applications.
Health & Life Sciences